Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial. - Aggarwal R; Bhatt DL; Szarek M; Cannon CP; Leiter LA; Inzucchi SE; Lopes RD; McGuire DK; Lewis JB; Riddle MC; Davies MJ; Banks P; et al. (The lancet. Diabetes & endocrinology, 2025)